Matthias Karajannis
Chief, Pediatric Neuro-Oncology Service · New York Presbyterian Hospital
Credentials: · · · ·
History
PresentPediatric Neuro-Oncology Service Division · New York Presbyterian Hospital
1997–2000
- 1993–1997
Research
DNA methylation-based classification of central nervous system tumours
Nature · 2018 · 2,405 citations
Cancer Cell · 2015 · 926 citations
New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs
Cell · 2016 · 744 citations
28 papers
24 papers
- JA
21 papers
- MR
18 papers
- TB
16 papers
15 papers
- ML
13 papers
12 papers
Grants
- 2012–2019
Exploration of Activity of RAD001 in vivo in Vestibular Schwannomas and Meningiom
National Cancer Institute · R01
Contact PI · $1.5M · New York University School of Medicine
Clinical trials
- 2022–2027
131I-Omburtamab, in Recurrent Medulloblastoma and Ependymoma
Principal investigator · Active not recruiting · Phase 2
Pediatric Brain Tumor Consortium
- 2018–2026
Principal investigator · Active not recruiting · Phase 2
National Cancer Institute (NCI)
- 2011–2013
Phase II Study of Everolimus (RAD001) in Children and Adults With Neurofibromatosis Type 2
Principal investigator · Completed · Phase 2
NYU Langone Health
- 2011–2013
Sorafenib in Children and Young Adults With Recurrent or Progressive Low-Grade Astrocytomas
Principal investigator · Terminated · Phase 2
NYU Langone Health